Property, Plant and Equipment, Gross in USD of Karyopharm Therapeutics Inc. from Q4 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
Karyopharm Therapeutics Inc. quarterly Property, Plant and Equipment, Gross history and growth rate from Q4 2012 to Q4 2024.
  • Karyopharm Therapeutics Inc. Property, Plant and Equipment, Gross for the quarter ending December 31, 2024 was $7.09M, a 1.12% decline year-over-year.
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Growth (%)

Karyopharm Therapeutics Inc. Quarterly Property, Plant and Equipment, Gross (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $7.09M -$80K -1.12% Dec 31, 2024 10-K 2025-02-19
Q4 2023 $7.17M -$613K -7.88% Dec 31, 2023 10-K 2025-02-19
Q4 2022 $7.78M +$85K +1.1% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $7.7M +$292K +3.94% Dec 31, 2021 10-K 2023-02-17
Q4 2020 $7.41M +$119K +1.63% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $7.29M +$132K +1.85% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $7.16M +$2.41M +50.9% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $6.01M +$1.33M +28.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $5.52M +$841K +18% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $5.18M +$499K +10.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $4.74M +$62K +1.33% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $4.69M +$32K +0.69% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $4.68M +$25K +0.54% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $4.68M +$32K +0.69% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $4.68M +$70K +1.52% Dec 31, 2016 10-K 2018-03-15
Q3 2016 $4.66M +$45K +0.98% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $4.66M +$638K +15.9% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $4.65M +$738K +18.9% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $4.61M +$1.36M +42% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $4.61M +$1.51M +48.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $4.02M +$2.98M +287% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $3.91M +$3.2M +447% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $3.25M +$2.66M +451% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $3.1M +$2.54M +455% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $1.04M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $715K Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $590K +$57K +10.7% Dec 31, 2013 10-K 2015-03-13
Q3 2013 $558K Sep 30, 2013 10-Q/A 2013-12-23
Q4 2012 $533K Dec 31, 2012 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.